Finance

Lists
Outlook: 34.8% bullish·0.0% bearish
Go to analysis
PFIZ34:BVMF
Pfizer BDR
R$35.15
0.00%
(0.00) 1D
Oct 9, 5:05:00 PM GMT-3  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for PFIZ34...
Open
R$35.15
High
R$35.24
Low
R$34.65
Mkt. cap
161.19B
Avg. vol.
8.98K
Volume
16.59K
52-wk high
R$37.70
52-wk low
R$30.09
Shares outstanding
5.70B
No. of employees
361K
Open
R$35.15
High
R$35.24
Low
R$34.65
Mkt. cap
161.19B
Avg. vol.
8.98K
Volume
16.59K
52-wk high
R$37.70
52-wk low
R$30.09
Shares outstanding
5.70B
No. of employees
361K
News stories
From web sources and news partners
Profile
PetroChina Company Limited is a Chinese oil and gas company and is the listed arm of state-owned China National Petroleum Corporation, headquartered in Dongcheng District, Beijing. The company is currently Asia's largest oil and gas producer. Traded in Hong Kong and New York, the mainland enterprise announced its plans to issue stock in Shanghai in November 2007, and subsequently entered the constituent of SSE 50 Index. In the 2020 Forbes Global 2000, PetroChina was ranked as the 32nd-largest public company in the world. Wikipedia
About Pfizer BDR
CEONgit Liong Wong | Albert Bourla | Thapana Sirivadhanabhakdi | Ngit Liong Wong
Employees361K
Founded1849
HeadquartersNew York, New York, United States
SectorDistillery
Last report
Aug 4, 2026
Fiscal period
Q2 2026
$0.77 / $0.68
+12.87%beat
Revenue / Est. (USD)
15.03B / 14.39B
+4.49%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
16.65B
17.56B
14.45B
15.03B
Cost of goods sold
3.98B
5.06B
3.41B
3.66B
Cost of revenue
3.98B
5.06B
3.41B
3.66B
Research and development expenses
2.49B
3.32B
2.45B
2.75B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.08B
3.74B
2.84B
3.26B
Operating expense
6.80B
8.29B
6.48B
7.19B
Total operating expenses
10.78B
13.35B
9.88B
10.84B
Operating income
5.88B
4.20B
4.57B
4.19B
Other non operating income
181.00M
1.35B
36.00M
515.00M
EBT including unusual items
3.33B
-1.64B
3.17B
-653.00M
EBT excluding unusual items
5.54B
5.09B
4.13B
4.25B
Income tax expense
-216.00M
-2.00M
461.00M
-407.00M
Effective tax rate
-6.48%
0.12%
14.55%
62.33%
Other operating expenses
-
-
-
-
Net income
3.54B
-1.65B
2.69B
-248.00M
Net profit margin
21.26%
-9.39%
18.59%
-1.65%
Earnings per share
0.87
0.66
0.75
0.77
Interest and investment income
138.00M
247.00M
197.00M
211.00M
Interest expense
-652.00M
-711.00M
-668.00M
-667.00M
Net interest expenses
-514.00M
-464.00M
-471.00M
-456.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
7.53B
5.86B
6.18B
5.80B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google apps